| Vol. 7.38 – 13 October, 2023 |
| |
|
|
| Researchers employed a proliferation recording system, ProTracer, to examine the spatial-temporal proliferation of hepatocytes during pregnancy. [Cell Stem Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors demonstrated that the expression of fibroblast growth factor 18 (Fgf18) was elevated in mouse livers following the induction of chronic liver fibrosis models. [Nature Communications] |
|
|
|
| Scientists showed tripartite motif containing 26 (TRIM26) to be a critical endogenous suppressor of CCAAT/enhancer binding protein delta (C/EBPδ), and confirmed that TRIM26 was an C/EBPδ-interacting partner protein that catalyzed the ubiquitination degradation of C/EBPδ in hepatocytes. [Nature Communications] |
|
|
|
| Immunohistochemical analyses of cholangiocarcinoma (CCA) samples revealed a high expression of phosphatidylinositol-3 kinase isoform δ (PI3Kδ) in the less differentiated CCA. [Liver International] |
|
|
|
| Growth differentiation factor 7 (GDF7) expression was analyzed in fibrotic and healthy human liver tissues by immunohistochemistry and qPCR. [Stem Cell Research & Therapy] |
|
|
|
| Researchers used iPSCs to develop human liver organoids that could emulate conjugation failure phenotype. Bilirubin conjugation assays, chromatin immunoprecipitation, and transcriptome analysis elucidated the role of glucocorticoid antagonism in UDP glucuronosyltransferase family 1 member A1 activation. [Stem Cell Reports] |
|
|
|
| The expression level of AP4M1 in cancers was investigated by The Cancer Genome Atlas and Gene Expression Omnibus databases, and the correlation between AP4M1 and HCC clinicopathological parameters were analyzed. [Cancer Cell International] |
|
|
|
| The authors developed a simple organ-on-a-chip steatosis model using the Mimetas OrganoPlate with a human liver cell line, HepG2. [Scientific Reports] |
|
|
|
|
|
| Scientists provide an up-to-date perspective on the natural history of nonalcoholic fatty liver disease (NAFLD), emphasizing the reversible nature of the disease, and summarizing possible mechanisms underlying recompensation in NAFLD. [Nature Reviews Gastroenterology & Hepatology] |
|
|
|
|
| The US FDA has approved the use of sound waves to break down tumors—a technique called histotripsy—in humans for liver treatment. [University of Michigan] |
|
|
|
|
| October 29 – November 3, 2023 Hinxton, England, United Kingdom |
|
|
|
|
|
| The University of Hong Kong – Hong Kong, Hong Kong |
|
|
|
| Texas Tech University Health Sciences Center El Paso – El Paso, Texas, United States |
|
|
|
| National University of Singapore – Singapore, Singapore |
|
|
|
| National University of Singapore – Singapore, Singapore |
|
|
|
| Houston Methodist Research Institute – Houston, Texas, United States |
|
|
|
|